Podcast: Play in new window | Download (Duration: 58:02 — 51.5MB) | Embed
Subscribe: Apple Podcasts | Spotify | Amazon Music | Android | Pandora | iHeartRadio | Podcast Index | TuneIn | RSS | More
Resistance resistance cancer therapies that last longer and hit harder. This is what Nick and Chris from Visoera are currently working on. They’ve been funded, been through YC, and are two amazing scientists turned entrepreneurs. They’ve also been on the show before.
Key links
https://www.viosera.com/
https://www.linkedin.com/in/nicholas-goldner/
https://www.linkedin.com/in/christopherbulow/
info@viosera.com
https://www.youtube.com/watch?v=WQg1qnwtufA
Last episode we did.
10: Nicholas Goldner, CEO, and Christopher Bulow, COO, of Viosera